Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World Analysis

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2025-10-29
DOI
https://doi.org/10.1002/jha2.70152
Citations
1
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World Analysis

Nieves López‐Muñoz, Adolfo Sáez, Gonzalo Carreño‐Tarragona, Alberto Blanco Sánchez et al.
1 citations
eJHaem
Myeloproliferative Neoplasms: Diagnosis and Treatment
1.63
article

Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World Analysis

Nieves López‐Muñoz, Adolfo Sáez, Gonzalo Carreño‐Tarragona, Alberto Blanco Sánchez, Rosa María Ayala, María Luisa Palacios‐Berraquero, Joaquín Martínez‐López, Rafael Colmenares
article en
1 citations

Abstract

No abstract available for this paper.
eJHaemVol. 6(6)
Universidad Complutense de Madrid (ES), Research Institute Hospital 12 de Octubre (ES)
CRIS Cancer Foundation
Openalex Percentile: Top 12%
Myeloproliferative Neoplasms: Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.